Mondino A - Search Results

1

Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer.

Bellone M, Mondino A, Corti A. Bellone M, et al. Among authors: mondino a. Trends Immunol. 2008 May;29(5):235-41. doi: 10.1016/j.it.2008.02.003. Epub 2008 Mar 28. Trends Immunol. 2008. PMID: 18375183 Review.

2

Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

Camporeale A, Boni A, Iezzi G, Degl'Innocenti E, Grioni M, Mondino A, Bellone M. Camporeale A, et al. Among authors: mondino a. Cancer Res. 2003 Jul 1;63(13):3688-94. Cancer Res. 2003. PMID: 12839960

3

uPA and uPAR in fibrinolysis, immunity and pathology.

Mondino A, Blasi F. Mondino A, et al. Trends Immunol. 2004 Aug;25(8):450-5. doi: 10.1016/j.it.2004.06.004. Trends Immunol. 2004. PMID: 15275645 Review. No abstract available.

4

The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration.

Casati A, Zimmermann VS, Benigni F, Bertilaccio MT, Bellone M, Mondino A. Casati A, et al. Among authors: mondino a. J Immunol. 2005 Mar 15;174(6):3317-25. doi: 10.4049/jimmunol.174.6.3317. J Immunol. 2005. PMID: 15749863

5

Immune surveillance and anti-tumor immune responses: an anatomical perspective.

Zimmermann VS, Benigni F, Mondino A. Zimmermann VS, et al. Among authors: mondino a. Immunol Lett. 2005 Apr 15;98(1):1-8. doi: 10.1016/j.imlet.2004.09.005. Immunol Lett. 2005. PMID: 15790503 Review.

6

Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors.

Hess Michelini R, Freschi M, Manzo T, Jachetti E, Degl'Innocenti E, Grioni M, Basso V, Bonini C, Simpson E, Mondino A, Bellone M. Hess Michelini R, et al. Among authors: mondino a. Cancer Res. 2010 May 1;70(9):3505-14. doi: 10.1158/0008-5472.CAN-09-4253. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388780

7

Concurrent allorecognition has a limited impact on posttransplant vaccination.

Manzo T, Hess Michelini R, Basso V, Ricupito A, Chai JG, Simpson E, Bellone M, Mondino A. Manzo T, et al. Among authors: mondino a. J Immunol. 2011 Feb 1;186(3):1361-8. doi: 10.4049/jimmunol.1002030. Epub 2011 Jan 5. J Immunol. 2011. PMID: 21209285

8

Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy.

Calcinotto A, Grioni M, Jachetti E, Curnis F, Mondino A, Parmiani G, Corti A, Bellone M. Calcinotto A, et al. Among authors: mondino a. J Immunol. 2012 Mar 15;188(6):2687-94. doi: 10.4049/jimmunol.1101877. Epub 2012 Feb 8. J Immunol. 2012. PMID: 22323546

9

Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings.

Ricupito A, Grioni M, Calcinotto A, Hess Michelini R, Longhi R, Mondino A, Bellone M. Ricupito A, et al. Among authors: mondino a. Cancer Res. 2013 Jun 15;73(12):3545-54. doi: 10.1158/0008-5472.CAN-12-2449. Epub 2013 Mar 28. Cancer Res. 2013. PMID: 23539449

10

Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation.

Hess Michelini R, Manzo T, Sturmheit T, Basso V, Rocchi M, Freschi M, Listopad J, Blankenstein T, Bellone M, Mondino A. Hess Michelini R, et al. Among authors: mondino a. Cancer Res. 2013 Aug 1;73(15):4641-52. doi: 10.1158/0008-5472.CAN-12-3464. Epub 2013 Jun 7. Cancer Res. 2013. PMID: 23749644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters